Incidence and phenotype at diagnosis of inflammatory bowel disease. Results in Spain of the EpiCom study

Gastroenterologia y Hepatologia

Volumn 38, Issue 9, 2015, Pages 534-540

  Fernández, Alberto ^a   Hernández, Vicent ^b,c   Martínez Ares, David ^b,c,d   Sanromán, Luciano ^b,c   de Castro, María Luisa ^b,c   Pineda, Juan Ramón ^b,c,e   Carmona, Amalia ^a   González Portela, Carlos ^a   Salgado, Carlos ^b   Martínez Cadilla, Jesús ^b,c   Pereira, Santos ^b,c   García Burriel, Jose Ignacio ^b   Vázquez, Santiago ^a   Rodríguez Prada, Ignacio ^b,c  

^a HOSPITAL POVISA   (Spain)

^b UNIVERSITY HOSPITAL COMPLEX OF VIGO   (Spain)

^c Institute for Biomedical Research of Vigo   (Spain)

^d HOSPITAL PERPETUO SOCORRO   (Spain)

^e Hospital Fátima   (Spain)

Author keywords

Crohn disease; Epidemiology; Incidence; Inflammatory bowel diseases; Ulcerative colitis

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; CLINICAL FEATURE; CROHN DISEASE; DESCRIPTIVE RESEARCH; DISEASE CLASSIFICATION; EPIDEMIOLOGICAL DATA; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PHENOTYPE; POPULATION RESEARCH; PROSPECTIVE STUDY; SEX DIFFERENCE; SMOKING HABIT; SPAIN; ULCERATIVE COLITIS; ANTIBODY SPECIFICITY; COLITIS, ULCERATIVE; FACTUAL DATABASE; INFLAMMATORY BOWEL DISEASES; MIDDLE AGED; PRESCHOOL CHILD; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; CROHN DISEASE; DATABASES, FACTUAL; FEMALE; HUMANS; INCIDENCE; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; ORGAN SPECIFICITY; PHENOTYPE; PROSPECTIVE STUDIES; SPAIN; YOUNG ADULT;

EID: 84944356461     PISSN: 02105705     EISSN: 15789519     Source Type: Journal    
DOI: 10.1016/j.gastrohep.2015.03.001     Document Type: Article

References (37)

1. Molodecky N.A., Soon I.S., Rabi D.M., Ghali W.A., Ferris M., Chernoff G., et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012, 142:46-54.
2. Burisch J., Pedersen N., Cukovic-Cavka S., Brinar M., Kaimakliotis I., Duricova D., et al. East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort. Gut 2014, 63:588-597.
3. Jacobsen B.A., Fallingborg J., Rasmussen H.H., Nielsen K.R., Drewes A.M., Puho E., et al. Increase in incidence and prevalence of inflammatory bowel disease in northern Denmark: a population-based study, 1978-2002. Eur J Gastroenterol Hepatol 2006, 18:601-606.
4. Loftus E.V. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004, 126:1504-1517.
5. Shivananda S., Lennard-Jones J., Logan R., Fear N., Price A., Carpenter L., et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 1996, 39:690-697.
6. Molinié F., Gower-Rousseau C., Yzet T., Merle V., Grandbastien B., Marti R., et al. Opposite evolution in incidence of Crohn's disease and ulcerative colitis in Northern France (1988-1999). Gut 2004, 53:843-887.
7. Burisch J., Munkholm P. Inflammatory bowel disease epidemiology. Curr Opin Gastroenterol 2013, 29:357-362.
8. Frangos C.C., Frangos C.C. Inflammatory bowel disease: reviewing an old study under a new perspective. Gut 2007, 56:1638-1639.
9. Burisch J. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort. Dan Med J 2014, 61:B4778.
10. Brullet E., Bonfill X., Urrútia G., Ruiz Ochoa V., Cueto M., Clofent J., et al. Epidemiological study on the incidence of inflammatory bowel disease in 4 Spanish areas. Spanish Group on the Epidemiological Study of Inflammatory Bowel Disease. Med Clin (Barc) 1998, 110:651-656.
11. Lopez Miguel C., Sicilia B., Sierra E., Lopez Zaborras J., Arribas F., Gomollon F. Incidence of inflammatory bowel disease in Aragon: outcome of a prospective population-based study. Gastroenterol Hepatol 1999, 22:323-328.
12. Saro Gismera C., Lacort Fernández M., Argüelles Fernández G., Antón Magarzo J., García López R., Navascues C.A., et al. Incidence and prevalence of inflammatory bowel disease in Gijon, Asturias, Spain. Gastroenterol Hepatol 2000, 23:322-327.
13. Garrido A., Martínez M.J., Ortega J.A., Lobato A., Rodríguez M.J., Guerrero F.J. Epidemiology of chronic inflammatory bowel disease in the Northern area of Huelva. Rev Esp Enferm Dig 2004, 96:687-691.
14. Rodrigo L., Riestra S., Niño P., Cadahía V., Tojo R., Fuentes D., et al. A population-based study on the incidence of inflammatory bowel disease in Oviedo (Northern Spain). Rev Esp Enferm Dig 2004, 96:296-305.
15. Arin Letamendia A., Borda Celaya F., Burusco Paternain M.J., Prieto Martínez C., Martínez Echeverría A., Elizalde Apestegui I., et al. High incidence rates of inflammatory bowel disease in Navarra (Spain). Results of a prospective, population-based study. Gastroenterol Hepatol 2008, 31:111-116.
16. Lopez-Serrano P., Perez-Calle J.L., Carrera-Alonso E., Perez-Fernández T., Rodriguez-Caravaca G., Boixeda-de-Mguel D., et al. Epidemiologic study on the current incidence of inflammatory bowel disease in Madrid. Rev Esp Enferm Dig 2009, 101:768-772.
17. Anton Martinez J., Ortega Gomez A., Arranz Carrero A., Molina Sancez A., Alvarez Garcia J.F., Moreiras Jimenez J.L., et al. Incidence of inflammatory bowel disease in the health area of Navalmoral de la Mata (Caceres Spain) between 2000 and 2009. Gastroenterol Hepatol 2010, 33:694-699.
18. Munkholm P. Crohn's disease - occurrence, course and prognosis. An epidemiologic cohort-study. Dan Med Bull 1997, 44:287-302.
19. Langholz E. Ulcerative colitis. An epidemiological study based on a regional inception cohort, with special reference to disease course and prognosis. Dan Med Bull 1999, 46:400-415.
20. Silverberg M.S., Satsangi J., Ahmad T., Arnott I.D.R., Bernstein C.N., Brant S.R., et al. Towards an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005, (19 Suppl. A):5A-36A.
21. Burisch J., Cukovic-Cavka S., Kaimakliotis I., Shonová O., Andersen V., Dahlerup J.F., et al. Construction and validation of a web-based epidemiological database for inflammatory bowel diseases in Europe. An EpiCom study. J Crohns Colitis 2011, 342-349.
22. Ruiz Ochoa V. Epidemiologic study of Crohn's disease in Galicia from 1976 to 1983. Rev Esp Enferm Apar Dig 1984, 66:273-279.
23. Lucendo A.J., Hervias D., Roncero O., Lorente R., Bouhmidi A., Angueira T., et al. Epidemiology and temporal trends (2000-2012) of inflammatory bowel disease in adult patients in a central region of Spain. Eur J Gastroenterol Hepatol 2014, 26:1399-4074.
24. Costas Armada P., Garcia-Mayor R.V., Larrañaga A., Sequin P. Prevalence and incidence of Crohn's disease in Galicia, Spain. Med Clin (Barc) 2008, 130:715.
25. Jess T., Riis L., Vind I., Winther K.V., Borg S., Binder V., et al. Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark. Inflamm Bowel Dis 2007, 13:481-489.
26. Loftus E.V., Schoelnfeld P., Sandborn W.J. The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review. Aliment Pharmacol Ther 2002, 16:51-60.
27. Loftus E.V., Silverstein M.D., Sandborn W.T., Tremaine W.J., Harsmen W.S., Zinsmeister A.R. Ulcerative colitis in Olmsted country, Minnesota 1940-1993. Incidence, prevalence and survival. Gut 2000, 46:336-343.
28. Louis E., Collard A., Oger F.A., Degroote E., Aboul Nasr El Yafi F., Belaiche J. Behaviour of Crohn's disease according to the Viena classification: changing pattern over the ourse of disease. Gut 2001, 49:777-782.
29. Cosnes J., Cattan S., Blain A., Beaugerie L., Carbonnel F., Parc R., et al. Long-term evolution of disease. Behavior of Crohn's disease. Inflamm Bowel Dis 2002, 8:244-250.
30. Romberg-Camps M.J., Dagnelie P.C., Kester A.D., Hesselink-van de Kruijs M.A., Cilissen M., Engels L.G., et al. Influence of phenotype at diagnosis and other potential prognostic factors on the course of inflammatory bowel disease. Am J Gastroenterol 2009, 104:371-383.
31. Mahid S.S., Minor K.S., Soto R.E., Hornung C.A., Galandiuk S. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc 2006, 81:1462-1471.
32. Höie O., Wolters F., Riis L., Aamodt G., Soldberg C., Berklev T., et al. Ulcerative colitis: patient characteristics may predict 10-yr disease recurrence in a European-wide population-based cohort. Am J Gastroenterol 2007, 102:1692-1701.
33. Cosnes J. Tobacco and IBD: relevance in the understanding of disease mechanism and clinical practice. Best Pract Res Clin Gastroenterol 2004, 18:481-496.
34. Beaugerie L., Massot N., Carbonnel F., Cattan S., Gendre J.P., Cosnes J. Impact of cessation of smoking on the course of ulcerative colitis. Am J Gastroenterol 2001, 96:2113-2116.
35. Regueiro M.K.I.P., Cheung K.E., Hegazi O.R.A., Plevy S. Cigarette smoking and age at diagnosis if inflammatory bowel disease. Inflamm Bowel Dis 2005, 11:42-47.
36. Cosnes J., Carbonnel F., Beaugerie L., Le Quintrec Y., Gendre J.P. Effects of cigarette smoking on the long-term course of Crohn's disease. Gastroenterology 1996, 110:424-431.
37. van der Heide F., Dijkstra A., Weersma R.K., Albersnagel F.A., van der Logt E.M., Faber K.N., et al. Effects of active and passive smoking on disease course of Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 2009, 15:1199-1207.